MEF2A and atherosclerosis: In the present study, we investigated the progression of atherosclerosis by examining inflammation in apolipoprotein E-deficient mice (APOE KO) following delivering MEF2A shRNA and found that silencing MEF 2A accelerates atherosclerosis.